Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Left Arrow
    Right Arrow

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission at MANA Therapeutics is to develop unique “off-the-shelf” or “ready to use” cellular therapies that improve outcomes for cancer patients. Our name, MANA, is a word from the Maori culture where it is believed that one’s “Mana,” a force that drives leadership, character and influence, is strengthened by helping and caring for others. MANA was founded in November 2018, based on the research and human pro...
    Our mission at MANA Therapeutics is to develop unique “off-the-shelf” or “ready to use” cellular therapies that improve outcomes for cancer patients. Our name, MANA, is a word from the Maori culture where it is believed that one’s “Mana,” a force that drives leadership, character and influence, is strengthened by helping and caring for others. MANA was founded in November 2018, based on the research and human proof-of-concept clinical trials conducted by Dr. Catherine Bollard and her team at Children’s National Hospital (CNH) in Washington, D.C along with colleagues at Johns Hopkins Medical Center.

    List your booth number for exhibitions, ask us

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.